Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Rescue haploidentical peripheral blood stem cell transplantation for engraftment failure: a single-centre case series.

Kliman D, Bilmon I, Kwan J, Blyth E, Micklethwaite K, Panicker S, Bhattacharyya A, Deren S, Antonenas V, Huang G, Gottlieb D.

Intern Med J. 2018 Aug;48(8):988-991. doi: 10.1111/imj.13979.


Anncaliia algerae Microsporidial Myositis, New South Wales, Australia.

Sutrave G, Maundrell A, Keighley C, Jennings Z, Brammah S, Wang MX, Pamphlett R, Webb CE, Stark D, Englert H, Gottlieb D, Bilmon I, Watts MR.

Emerg Infect Dis. 2018 Aug;24(8):1528-1531. doi: 10.3201/eid2408.172002.


Low dose PD-1 inhibition in relapsed refractory Hodgkin lymphoma after allogeneic stem cell transplant with concomitant active GVHD.

Minson A, Douglas G, Bilmon I, Grigg A.

Br J Haematol. 2018 Mar 13. doi: 10.1111/bjh.15186. [Epub ahead of print] No abstract available.


Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse.

Lim ABM, Curley C, Fong CY, Bilmon I, Beligaswatte A, Purtill D, Getta B, Johnston AM, Armytage T, Collins M, Mason K, Fielding K, Greenwood M, Gibson J, Hertzberg M, Wright M, Lewis I, Moore J, Curtis D, Szer J, Kennedy G, Ritchie D.

Intern Med J. 2018 Mar;48(3):276-285. doi: 10.1111/imj.13522.


Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials.

Ramanayake S, Bilmon I, Bishop D, Dubosq MC, Blyth E, Clancy L, Gottlieb D, Micklethwaite K.

Cytotherapy. 2015 Sep;17(9):1251-67. doi: 10.1016/j.jcyt.2015.05.013. Epub 2015 Jul 23.


Influence of Stem Cell Source on Outcomes of Allogeneic Reduced-Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors.

Bradstock K, Bilmon I, Kwan J, Blyth E, Micklethwaite K, Huang G, Deren S, Byth K, Gottlieb D.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1641-5. doi: 10.1016/j.bbmt.2015.06.006. Epub 2015 Jun 14.


Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen-Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease.

Bradstock KF, Bilmon I, Kwan J, Micklethwaite K, Blyth E, Deren S, Bayley A, Gebski V, Gottlieb D.

Biol Blood Marrow Transplant. 2015 May;21(5):941-4. doi: 10.1016/j.bbmt.2015.01.020. Epub 2015 Jan 27.


Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning.

Bilmon I, Nivison-Smith I, Hertzberg M, Ritchie D, Greenwood M, Spencer A, Kennedy G, Bryant A, Moore J.

Bone Marrow Transplant. 2014 Jun;49(6):852-3. doi: 10.1038/bmt.2014.23. Epub 2014 Mar 3. No abstract available.


Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study.

Bilmon IA, Ashton LJ, Le Marsney RE, Dodds AJ, O'Brien TA, Wilcox L, Nivison-Smith I, Daniels B, Vajdic CM; CAST study group.

Bone Marrow Transplant. 2014 May;49(5):691-8. doi: 10.1038/bmt.2014.13. Epub 2014 Feb 17.


Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centre.

Bilmon IA, Kwan J, Gottlieb D, Kerridge I, McGurgan M, Huang G, George B, Hertzberg M, Bradstock KF.

Intern Med J. 2013 Feb;43(2):191-6. doi: 10.1111/j.1445-5994.2012.02843.x.


Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients.

Blyth E, Gaundar SS, Clancy L, Simms RM, Bilmon I, Micklethwaite KP, Gottlieb DJ.

Cytotherapy. 2012 Jul;14(6):724-32. doi: 10.3109/14653249.2012.663486. Epub 2012 Mar 12.


Supplemental Content

Loading ...
Support Center